Aug 13, 2020
ChemDiv Created Unique KATO TM Platform for Development of Innovative Drugs Against Coronavirus Infection
Jun 22, 2020
Hisun Pharmaceutical: Free of COVID-19, Governments Suggest Favipiravir
Jun 20, 2020
Glenmark Becomes the First Pharmaceutical Company in India to Receive Regulatory Approval for Oral Antiviral Favipiravir, for the Treatment of Mild to Moderate COVID-19
Jun 01, 2020
RDIF and ChemRar to Deliver 60,000 Courses of the First COVID-19 Drug Registered in Russia, Avifavir, to the Country's Hospitals in June
May 26, 2020
Glenmark to Commence New Phase 3 Clinical Trial on Combination of Two Anti-viral Drugs Favipiravir and Umifenovir in Hospitalized Patients of Moderate COVID-19 in India
May 22, 2020
RDIF and ChemRar Launch Final Stage of Favipiravir Clinical Trial
May 13, 2020
RDIF and ChemRar Announce First Interim Results of Clinical Trials of Favipiravir Drug's Effectiveness in Coronavirus Therapy
May 12, 2020
Glenmark Initiates Phase 3 Clinical Trials on Antiviral Favipiravir for COVID-19 Patients in India
Apr 23, 2020
CMIC Group Supports Clinical Trials and Manufacturing of Influenza Antiviral Drug “Avigan® Tablet” and Contributes to Accelerating Provision for COVID-19 Patients
Apr 15, 2020
Fujifilm accelerates production of its influenza antiviral drug "Avigan® Tablet" for COVID-19
Apr 08, 2020
Viriom Initiates Phase 2 Clinical Study of Elsulfavirine for Treatment of COVID-19
Mar 19, 2020
Zhejiang Hisun Pharmaceutical Co. Ltd.: Favipiravir Works - Preliminary Clinical Studies Suggest Positive Effects on COVID-19 Patients